Live stream preview
OS Therapies CEO on clinical advancements in immunotherapy for osteosarcoma
Floor Talk
•
4m 43s
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
Up Next in Floor Talk
-
Alice CEO Noam Schwartz Reveals How A...
Alice CEO Noam Schwartz joins Ashley Mastronardi on NYSE Floor Talk
-
CoachHub CEO on making coaching more ...
Matti Niebelschütz, CEO & Co-Founder of CoachHub, discusses the future of coaching in the ‘people era,’ how AI is making coaching more accessible, and the role of AIMY™ AI Coach in transforming workplace learning on #NYSEFloorTalk with Judy Shaw.
-
U.S. Olympic Skating Couple Madison C...
U.S. Olympic Skating Couple Madison Chock and Evan Bates join Kristen Scholer on NYSE Floor Talk
